(Q38313501)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Benoit V

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

de Moraes E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Dar NA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Taranchon E

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Bours V

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Hautefeuille A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Tanière P

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Chariot A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Scoazec JY

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

de Moura Gallo CV

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Merville MP

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

8 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

5708-5718

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209579

20 January 2020

exact match

0 references

cites work

Inactivation of the p53 protein in cell lines derived from human esophageal cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

NF- kappa B and chemoresistance: could NF- kappa B be an antitumor target?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

NF-kappa B activation by ultraviolet light not dependent on a nuclear signal.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cell cycle-dependent expression of cyclooxygenase-2 in human fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Selective COX-2 inhibitor, NS-398, inhibits the replicative senescence of cultured dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cyclooxygenase-1 and -2 isoenzymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

COX-2-dependent stabilization of survivin in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Role of NF-κB in p53-mediated programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

p53: traffic cop at the crossroads of DNA repair and recombination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Classification of adenocarcinoma of the oesophagogastric junction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cyclooxygenase 2, p53, beta-catenin, and APC protein expression in gastric adenomatous polyps.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Inhibition of cyclooxygenase-2 gene expression by p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cyclooxygenase isozymes and their gene structures and expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Transcriptional cross talk between NF-kappaB and p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Transcriptional Control of COX-2 via C/EBPbeta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cell division and cell survival in the absence of survivin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209579

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209579

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16682957%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 January 2020

0 references

1 reference